成大生物 (688739)

1. Key Indicators

• Total Shares(W): 41645.00
• Circulating A-Shares(W): 41645.00
• Earnings Per Share(RMB): 0.4000
• Net Assets Per Share(RMB): 22.5410
• Operating Revenue(W RMB): 109588.66
• Total Profit(W RMB): 21114.75
• **Net Profit Attributable to Parent(W RMB) **: 16481.20
• Net Profit Growth Rate(%): -50.01
• Weighted Return on Equity(%): 1.7400
• Operating Cash Flow Per Share(RMB): 0.4110
• Undistributed Profit Per Share(RMB): 9.3387
• Capital Reserve Per Share(RMB): 12.0883

---

2. Main Business

The main business covers:

• Research, development, production, and sales of human vaccines

---

3. Company Basic Information

• Company Name: Liaoning Chengda Biotechnology Co., Ltd.
• Listing Date: 2021-10-28
• Industry: Pharmaceutical Manufacturing
• Address: No. 1 Xinfang Street, Hunnan New District, Shenyang City, Liaoning Province
• Website: https://www.cdbio.cn
• Company Profile: The company was established by transforming Chengda Co., Ltd. into a joint stock limited company as of the base date of October 31, 2010, based on the audited net asset value.

---

4. Top 10 Circulating Shareholders

Rank	Institution Name	Institution Type	Shares Held (W)	Percentage Held (%)
1	Liaoning Chengda Co., Ltd.	Corporate Legal Person	22766.38	54.67
2	Hong Kong Securities Clearing Company Ltd.	Northbound Capital	191.24	0.46
3	Southern China Securities 1000 ETF	Fund	190.11	0.46
4	Shanghai Orient Securities Innovation Investment Co., Ltd.	Corporate Legal Person	170.00	0.41
5	Penghua SSE STAR Market 100 ETF	Fund	125.57	0.30
6	Bosera SSE STAR Market 100 ETF	Fund	119.83	0.29
7	ChinaAMC China Securities 1000 ETF	Fund	113.19	0.27

---

5. Concept Sectors

• Biological Vaccines
• Margin Trading & Securities Lending
• Share Buyback Plan
• Below IPO Price
• High Dividend Stocks
• SSE Governance
• STAR Market Biotech
• STAR Market 100
• SSE 580

---

Remarks

• Data update date: 2025-11-03
• Data source: Public Market Information